Admin Core
Admin Core
批准号:
10696162
负责人:
Jean-Pierre J. Issa
金额:
$40.02万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-08-16 至 2026-06-30
关键词:
AddressAdministratorAdvocateAwardCancer PrognosisClinicClinicalClinical TrialsCollaborationsCommunicationComplexConsultationsDataDecision MakingDevelopmentElectronic MailEligibility DeterminationEnsureGenomicsGrantInfrastructureInstitutionInterdisciplinary StudyLaboratoriesLeadershipMalignant NeoplasmsMedical ResearchMinorityMonitorNational Cancer InstituteOutcomePathologyPatientsPoliciesPreparationProgress ReportsProtocols documentationPublicationsQuality ControlRegulationReportingResearchResearch ActivityResearch InfrastructureResearch PersonnelResearch Project GrantsResource SharingStrategic PlanningSupervisionTherapeutic StudiesTranslational ResearchUnited States National Institutes of HealthWomanWorkcancer carecancer therapycareerclinical research sitedata sharingdesignepigenetic therapyexperienceimprovedinterdisciplinary collaborationlecturesmeetingsnovelnovel therapeutic interventionprogramsquality assurancerecruitscreeningsuccesssymposiumweb site
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
The Administrative Core will provide essential support to the Coriell Institute for Medical Research (Coriell) and
Van Andel Institute (VAI) Epigenetic Therapy SPORE PIs and investigators to maximize success. It will be co-
directed by Drs. Jean-Pierre Issa, Stephen Baylin, and Peter Jones, who co-chair the Executive Committee and
provide overall supervision of three Projects, two additional Cores, Developmental Research (DRP) and Career
Enhancement (CEP) Programs, and scientific direction of the SPORE. The Core Co-Directors will rely on the
extensive broad-based scientific, research, and SPORE experience of the Internal and External Advisory Boards
in critical decision making. An oversight committee consisting of the SPORE PIs and three clinical experts from
the VAI-SU2C team (Drs. Rudin, El-Khoueiry and O’Connell) will ensure prioritization of SPORE trials within the
VAI-SU2C team and at clinical sites. Success of the complex interdisciplinary research in the SPORE depends
on integration of diverse epigenetic therapy research approaches. The Core will overcome barriers to
interdisciplinary collaboration and data sharing and will ensure a unified translational research effort. The SPORE
will be founded on planning, integration, and translational research efforts supported by this Core. Its leadership
and staff will be responsible for monitoring/planning scientific activities; providing scientific direction; ensuring
emphasis on translational research; ensuring interdisciplinary and inter-SPORE integration with major epigenetic
therapy programs within/outside Coriell and VAI and other broad translational research activities; and providing
optimal administrative and fiscal management. Specific responsibilities of the Core are: oversee and monitor all
SPORE activities; promote integration and communication among the SPORE-related clinical programs; monitor
the scientific integrity of all projects, and grant awards; assure compliance with institutional, governmental, and
National Cancer Institute regulations; oversee the fiscal and budgetary activities of the SPORE; coordinate data
control quality assurance issues; coordinate activities associated with clinical trials, including design of protocols,
approval by regulatory bodies, implementation, and eligibility screening and assignment of patients to different
studies; provide oversight and support for the shared Resources Cores; coordinate and manage meetings of the
SPORE Oversight Committee, Executive Committee, Internal and External Advisory Boards, investigator
meetings, research meetings, lectures, and symposia; administer the DRP and the CEP; coordinate
interdisciplinary and inter-SPORE interactions and exchanges/meetings with other Epigenetic Therapy SPORE
programs and investigators, and other SPORE programs; administer the activities of the Patient Advocates;
comply with, and improve policies addressing recruitment and retention of women and minorities; and maintain
a Epigenetic Therapy SPORE website focused on issues in epigenetic therapy translational research in cancers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Career Enhancement Program
-
批准号:10470369
-
项目类别:
-
资助金额:$8.25万
-
财政年份:2021
-
负责人:Jean-Pierre J. Issa
-
依托单位:
Career Enhancement Program
-
批准号:10696173
-
项目类别:
-
资助金额:$8.25万
-
财政年份:2021
-
负责人:Jean-Pierre J. Issa
-
依托单位:
Admin Core
-
批准号:10269640
-
项目类别:
-
资助金额:$38.72万
-
财政年份:2021
-
负责人:Jean-Pierre J. Issa
-
依托单位:
Career Enhancement Program
-
批准号:10269647
-
项目类别:
-
资助金额:$7.99万
-
财政年份:2021
-
负责人:Jean-Pierre J. Issa
-
依托单位:
Admin Core
-
批准号:10470362
-
项目类别:
-
资助金额:$40.02万
-
财政年份:2021
-
负责人:Jean-Pierre J. Issa
-
依托单位:
Developmental Research Program
-
批准号:10470368
-
项目类别:
-
资助金额:$8.25万
-
财政年份:2021
-
负责人:Jean-Pierre J. Issa
-
依托单位:
Developmental Research Program
-
批准号:10696172
-
项目类别:
-
资助金额:$8.25万
-
财政年份:2021
-
负责人:Jean-Pierre J. Issa
-
依托单位:
Cyclin Dependent Kinases as Epigenetic Therapy Targets
-
批准号:10269643
-
项目类别:
-
资助金额:$48.22万
-
财政年份:2021
-
负责人:Jean-Pierre J. Issa
-
依托单位:
Cyclin Dependent Kinases as Epigenetic Therapy Targets
-
批准号:10470365
-
项目类别:
-
资助金额:$49.82万
-
财政年份:2021
-
负责人:Jean-Pierre J. Issa
-
依托单位:
Cyclin Dependent Kinases as Epigenetic Therapy Targets
-
批准号:10696168
-
项目类别:
-
资助金额:$49.82万
-
财政年份:2021
-
负责人:Jean-Pierre J. Issa
-
依托单位:
Developmental Research Program
-
批准号:10269646
-
项目类别:
-
资助金额:$7.99万
-
财政年份:2021
-
负责人:Jean-Pierre J. Issa
-
依托单位:
Role of the microbiota in DNA methylation and CRC development
-
批准号:10058816
-
项目类别:
-
资助金额:$56.41万
-
财政年份:2017
-
负责人:Jean-Pierre J. Issa
-
依托单位:
Role of the microbiota in DNA methylation and CRC development
-
批准号:9905865
-
项目类别:
-
资助金额:$60.26万
-
财政年份:2017
-
负责人:Jean-Pierre J. Issa
-
依托单位:
Role of the microbiota in DNA methylation and CRC development
-
批准号:10311534
-
项目类别:
-
资助金额:$57.09万
-
财政年份:2017
-
负责人:Jean-Pierre J. Issa
-
依托单位:
Regulators of Cancer-Specific DNA Hypermethylation.
-
批准号:8549166
-
项目类别:
-
资助金额:$29.97万
-
财政年份:2012
-
负责人:Jean-Pierre J. Issa
-
依托单位:
Regulators of Cancer-Specific DNA Hypermethylation.
-
批准号:8222437
-
项目类别:
-
资助金额:$33.21万
-
财政年份:2012
-
负责人:Jean-Pierre J. Issa
-
依托单位:
Regulators of Cancer-Specific DNA Hypermethylation.
-
批准号:9110879
-
项目类别:
-
资助金额:$31.75万
-
财政年份:2012
-
负责人:Jean-Pierre J. Issa
-
依托单位:
Regulators of Cancer-Specific DNA Hypermethylation.
-
批准号:8713421
-
项目类别:
-
资助金额:$30.8万
-
财政年份:2012
-
负责人:Jean-Pierre J. Issa
-
依托单位:
Epigenetic Mechanisms of Neuropathic Pain
-
批准号:8706692
-
项目类别:
-
资助金额:$69.68万
-
财政年份:2011
-
负责人:Jean-Pierre J. Issa
-
依托单位:
Epigenetic Mechanisms of Neuropathic Pain
-
批准号:8306615
-
项目类别:
-
资助金额:$70.14万
-
财政年份:2011
-
负责人:Jean-Pierre J. Issa
-
依托单位:
海外基金